MeSH tree: D02.925.200.500
An oral combination treatment may prevent the progression of advanced leiomyosarcoma, one of the most common subtypes of soft tissue sarcoma, according to a recent study published in The Lancet Oncology. "These findings support ...
Feb 10, 2026
0
42
Glioblastoma (GBM) is one of the most common and aggressive primary brain tumors in adults, carrying an extremely poor prognosis and a median overall survival typically less than two years. Temozolomide (TMZ) is currently ...
Jan 13, 2026
0
9
Researchers at the UNC School of Medicine and the UNC Eshelman School of Pharmacy have made a breakthrough that could modernize treatment for glioblastoma. In a study published in Proceedings of the National Academy of Sciences, ...
Jan 5, 2026
0
26
Patients with the deadliest form of brain cancer, glioblastoma, who received MRI-guided focused ultrasound with standard-of-care chemotherapy had a nearly 40% increase in overall survival in a landmark trial of 34 patients ...
Nov 24, 2025
0
44
A patented RNA-based cocktail developed at the Italian Institute of Technology (IIT-Istituto Italiano di Tecnologia) has emerged as a promising active agent against tumors of the central nervous system, such as glioblastoma.
Nov 20, 2025
0
14
When doctors biopsy and treat cancer may be just as important as how they treat it. New research from Erik Herzog, Ph.D., the Viktor Hamburger Distinguished Professor in biology in Arts & Sciences at Washington University ...
Nov 20, 2025
0
14
Results of a study led by researchers at Roswell Park Comprehensive Cancer Center are shedding light on why some newly diagnosed glioblastoma patients survive longer than others after receiving standard treatment in conjunction ...
Oct 16, 2025
0
20
Previously, results from the photon cohort of the NRG-BN001, a signal seeking Phase II randomized trial, indicated that photon radiation dose intensification (75 Gy) did not demonstrate improvement in overall survival (OS) ...
Oct 1, 2025
0
13
Research has revealed a new mechanism within cancer cells that could be exploited to treat glioblastoma—one of the deadliest types of brain tumors.
Sep 2, 2025
0
28
NRG Oncology recently reported the results of the phase II/III NRG-BN007 clinical trial showing that combining ipilimumab and nivolumab with radiation therapy (RT) did not improve progression-free survival (PFS) for patients ...
Aug 13, 2025
0
21
